Healthcare
Live Price
Offline$1.14
-1.72% today
1Y Change
-24.66%
Window
Jun 20, 2025 → Jun 18, 2026
Coverage: 250 bars · Jun 20, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
VivoSim Labs, Inc. (VIVS) is a Healthcare stock with listed on NASDAQ. The stock last traded around $1.14 and down 24.7% across the available one-year price window (Jun 20, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of +32.1%, EPS growth of +91.2%, a dividend yield of 0.0%. What stands out right now is revenue +32.1%, EPS +91.2%, free cash flow +35.5% with operating margin -8066.2% and ROIC -228.3%. Valuation already assumes a fairly strong business story at price/sales 26.4. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines VIVS price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
VIVS
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
VIVS Max Drawdown
-76.99%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for VIVS and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
Latest Revenue
—
Latest Net Income
—
Free Cash Flow
—
Revenue Growth
+32.1%
EPS Growth
+91.2%
Gross Margin
100.0%
Net Margin
-864.1%
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.